Previous 10 | Next 10 |
2024-07-09 10:32:15 ET Summary Ingrezza Sprinkle, granules, has been recently granted with the FDA approval. Supporting $2.1-2.2 billion in 2024 sales for the whole Ingrezza franchise guided by Neurocrine’s management. Neurocrine Biosciences, Inc. has two new drug applicati...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-08 16:17:01 ET More on Kymera Therapeutics, Sanofi, etc. Sanofi's Immunology Business Is Doing A Lot Of Heavy Lifting Sanofi: A Leader In Life-Saving Vaccines And Treatments Kymera Therapeutics, Inc. (KYMR) Q1 2024 Earnings Call Transcript Sanofi, Reg...
2024-07-08 12:30:52 ET Summary Eli Lilly and Company is set to acquire Morphic Holding for $3.2bn. Morphic is focused on autoimmune disease drugs. Morphic's MORF-057 has a similar MoA to Takeda's ~$5bn per annum selling drug entyvio, but it is orally available, unlike the injectab...
2024-07-06 09:30:00 ET Summary This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks ...
2024-07-04 12:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Stock spinoffs typically don’t do well initially. Unloved by shareholders of the former parent company, often misunderstood by the market and sometimes laden with debt or other baggage t...
2024-07-04 11:30:00 ET Summary This article will present an in-depth analysis of drugs being developed to combat obesity and related diseases. Pharmaceutical companies are highly interested in the global obesity treatment market, which is expected to exceed $100 billion by 2030. ...
2024-07-03 12:59:59 ET More on Kamada Kamada Ltd. (KMDA) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Kamada Historical earnings data for Kamada Financial information for Kamada Read the full article on Seeking Alpha ...
2024-07-03 06:52:20 ET More on Sanofi, Regeneron, etc. Sanofi's Immunology Business Is Doing A Lot Of Heavy Lifting Sanofi: A Leader In Life-Saving Vaccines And Treatments Regeneron Pharmaceuticals, Inc. (REGN) Goldman Sachs 45th Annual Global Healthcare Conference (...
2024-07-02 11:20:47 ET Summary This article will outline nine steps I use to identify the most promising pharmaceutical companies and avoid investment pitfalls. In addition, each of the nine steps will provide examples of various factors and how they influence the assessment of th...
News, Short Squeeze, Breakout and More Instantly...
Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza Canada NewsWire TORONTO , July 26, 2024 /CNW/ - The National Advisory Committee on Immunization's (NACI) annual Statement...
Ontario Ministry of Health Announces a Universal Public Program with Beyfortus® this RSV Season Canada NewsWire TORONTO , July 25, 2024 /CNW/ - The Ontario Ministry of Health has announced a universal public program with Beyfortus ® (nirsevimab...